Condition

Carcinoma of the Breast

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

Generative AI Patient Education Module for Breast OncologyNCT07512271 · 2026-07-14

RECRUITING

ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsNCT02565758 · 2015-09-18

COMPLETED

Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsNCT01017185 · 2009-08-01

COMPLETED

Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast CancerNCT00542451 · 2007-10-01

COMPLETED

Common interventions

ABBV-085DRUG1HF10DRUG1OpenEvidence CareConnectOTHER1PaclitaxelDRUG1Survey (Participant)OTHER1Survey (Provider)OTHER1TrastuzumabDRUG1

Leading sponsors

AbbVie1Dana-Farber Cancer Institute1Takara Bio Inc.1University of California, San Francisco1

Trial status mix

COMPLETED3

RECRUITING1

Phase mix

PHASE12

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.